GYRO vs IONS · P/E 46, rev $1.8M vs rev $514.0M
Gyrodyne Company of America Inc (GYRO) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Gyrodyne Company of America Inc (GYRO) is a real estate services company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported GYRO revenue for 2015-08-31 was $1.8M. Net income was -$2.5M. Revenue was down 34.8% from 2014-12-31 to 2015-08-31. GYRO currently screens at market cap $20.0M and trailing P/E 45.5.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
GYRO currently screens at market cap $20.0M and trailing P/E 45.5. IONS currently screens at market cap $12.28B.
Not investment advice. Open the GYRO and IONS stock pages for the full models.
Not investment advice.